 | • レポートコード：D005-00381 • 出版社/出版日：GlobalInfoResearch / 2020年5月29日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、真核生物発現システムの世界市場を広く調査・分析し、今後の市場展望をまとめております。真核生物発現システムの種類別市場規模（MEL、COS、CHO、昆虫細胞）、用途別市場規模（試薬、発現ベクター、コンピテントセル）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher、Agilent、New England Biolabs、Sigma Aldrich、Promega、Jena Bioscience、Bio Rad、Takara Bio、Merck Millipore ・地域別グローバル市場分析 2015年-2020年 ・真核生物発現システムの北米市場（アメリカ、カナダ、メキシコ） ・真核生物発現システムのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・真核生物発現システムのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・真核生物発現システムの南米市場（ブラジル、アルゼンチン） ・真核生物発現システムの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：MEL、COS、CHO、昆虫細胞 ・用途別分析：試薬、発現ベクター、コンピテントセル ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Eukaryotic Expression Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Eukaryotic Expression Systems market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Eukaryotic Expression Systems market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Eukaryotic Expression Systems market has been segmented into:
MEL
COS
CHO
Insect cells
By Application, Eukaryotic Expression Systems has been segmented into:
Reagents
Expression vectors
Competent cells
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Eukaryotic Expression Systems market presented in the report. This section sheds light on the sales growth of different regional and country-level Eukaryotic Expression Systems markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Eukaryotic Expression Systems market.
The report offers in-depth assessment of the growth and other aspects of the Eukaryotic Expression Systems market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Eukaryotic Expression Systems Market Share Analysis
Eukaryotic Expression Systems competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Eukaryotic Expression Systems sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Eukaryotic Expression Systems sales, revenue and market share for each player covered in this report.
The major players covered in Eukaryotic Expression Systems are:
Thermo Fisher
Agilent
New England Biolabs
Sigma Aldrich
Promega
Jena Bioscience
Bio Rad
Takara Bio
Merck Millipore
Table of Contents
1 Eukaryotic Expression Systems Market Overview
1.1 Product Overview and Scope of Eukaryotic Expression Systems
1.2 Classification of Eukaryotic Expression Systems by Type
1.2.1 Global Eukaryotic Expression Systems Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Eukaryotic Expression Systems Revenue Market Share by Type in 2019
1.2.3 MEL
1.2.4 COS
1.2.5 CHO
1.2.6 Insect cells
1.3 Global Eukaryotic Expression Systems Market by Application
1.3.1 Overview: Global Eukaryotic Expression Systems Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Reagents
1.3.3 Expression vectors
1.3.4 Competent cells
1.4 Global Eukaryotic Expression Systems Market by Regions
1.4.1 Global Eukaryotic Expression Systems Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Eukaryotic Expression Systems (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Eukaryotic Expression Systems Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Eukaryotic Expression Systems Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Eukaryotic Expression Systems Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Eukaryotic Expression Systems Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Eukaryotic Expression Systems Status and Prospect (2015-2025)
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Thermo Fisher SWOT Analysis
2.1.4 Thermo Fisher Product and Services
2.1.5 Thermo Fisher Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
2.2 Agilent
2.2.1 Agilent Details
2.2.2 Agilent Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Agilent SWOT Analysis
2.2.4 Agilent Product and Services
2.2.5 Agilent Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
2.3 New England Biolabs
2.3.1 New England Biolabs Details
2.3.2 New England Biolabs Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 New England Biolabs SWOT Analysis
2.3.4 New England Biolabs Product and Services
2.3.5 New England Biolabs Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
2.4 Sigma Aldrich
2.4.1 Sigma Aldrich Details
2.4.2 Sigma Aldrich Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Sigma Aldrich SWOT Analysis
2.4.4 Sigma Aldrich Product and Services
2.4.5 Sigma Aldrich Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
2.5 Promega
2.5.1 Promega Details
2.5.2 Promega Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Promega SWOT Analysis
2.5.4 Promega Product and Services
2.5.5 Promega Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
2.6 Jena Bioscience
2.6.1 Jena Bioscience Details
2.6.2 Jena Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Jena Bioscience SWOT Analysis
2.6.4 Jena Bioscience Product and Services
2.6.5 Jena Bioscience Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
2.7 Bio Rad
2.7.1 Bio Rad Details
2.7.2 Bio Rad Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Bio Rad SWOT Analysis
2.7.4 Bio Rad Product and Services
2.7.5 Bio Rad Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
2.8 Takara Bio
2.8.1 Takara Bio Details
2.8.2 Takara Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Takara Bio SWOT Analysis
2.8.4 Takara Bio Product and Services
2.8.5 Takara Bio Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
2.9 Merck Millipore
2.9.1 Merck Millipore Details
2.9.2 Merck Millipore Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Merck Millipore SWOT Analysis
2.9.4 Merck Millipore Product and Services
2.9.5 Merck Millipore Eukaryotic Expression Systems Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Eukaryotic Expression Systems Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Eukaryotic Expression Systems Players Market Share
3.2.2 Top 10 Eukaryotic Expression Systems Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Eukaryotic Expression Systems Revenue and Market Share by Regions
4.2 North America Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
4.3 Europe Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
4.5 South America Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
5 North America Eukaryotic Expression Systems Revenue by Countries
5.1 North America Eukaryotic Expression Systems Revenue by Countries (2015-2020)
5.2 USA Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
5.3 Canada Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
5.4 Mexico Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
6 Europe Eukaryotic Expression Systems Revenue by Countries
6.1 Europe Eukaryotic Expression Systems Revenue by Countries (2015-2020)
6.2 Germany Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
6.3 UK Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
6.4 France Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
6.5 Russia Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
6.6 Italy Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Eukaryotic Expression Systems Revenue by Countries
7.1 Asia-Pacific Eukaryotic Expression Systems Revenue by Countries (2015-2020)
7.2 China Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
7.3 Japan Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
7.4 Korea Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
7.5 India Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
8 South America Eukaryotic Expression Systems Revenue by Countries
8.1 South America Eukaryotic Expression Systems Revenue by Countries (2015-2020)
8.2 Brazil Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
8.3 Argentina Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Eukaryotic Expression Systems by Countries
9.1 Middle East & Africa Eukaryotic Expression Systems Revenue by Countries (2015-2020)
9.2 Saudi Arabia Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
9.3 UAE Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
9.4 Egypt Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
9.5 South Africa Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Eukaryotic Expression Systems Revenue and Market Share by Type (2015-2020)
10.2 Global Eukaryotic Expression Systems Market Forecast by Type (2019-2024)
10.3 MEL Revenue Growth Rate (2015-2025)
10.4 COS Revenue Growth Rate (2015-2025)
10.5 CHO Revenue Growth Rate (2015-2025)
10.6 Insect cells Revenue Growth Rate (2015-2025)
11 Global Eukaryotic Expression Systems Market Segment by Application
11.1 Global Eukaryotic Expression Systems Revenue Market Share by Application (2015-2020)
11.2 Eukaryotic Expression Systems Market Forecast by Application (2019-2024)
11.3 Reagents Revenue Growth (2015-2020)
11.4 Expression vectors Revenue Growth (2015-2020)
11.5 Competent cells Revenue Growth (2015-2020)
12 Global Eukaryotic Expression Systems Market Size Forecast (2021-2025)
12.1 Global Eukaryotic Expression Systems Market Size Forecast (2021-2025)
12.2 Global Eukaryotic Expression Systems Market Forecast by Regions (2021-2025)
12.3 North America Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
12.4 Europe Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
12.6 South America Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Eukaryotic Expression Systems Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Eukaryotic Expression Systems by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Eukaryotic Expression Systems Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Eukaryotic Expression Systems Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Thermo Fisher Corporate Information, Location and Competitors
Table 6. Thermo Fisher Eukaryotic Expression Systems Major Business
Table 7. Thermo Fisher Eukaryotic Expression Systems Total Revenue (USD Million) (2017-2018)
Table 8. Thermo Fisher SWOT Analysis
Table 9. Thermo Fisher Eukaryotic Expression Systems Product and Solutions
Table 10. Thermo Fisher Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Agilent Corporate Information, Location and Competitors
Table 12. Agilent Eukaryotic Expression Systems Major Business
Table 13. Agilent Eukaryotic Expression Systems Total Revenue (USD Million) (2018-2019)
Table 14. Agilent SWOT Analysis
Table 15. Agilent Eukaryotic Expression Systems Product and Solutions
Table 16. Agilent Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. New England Biolabs Corporate Information, Location and Competitors
Table 18. New England Biolabs Eukaryotic Expression Systems Major Business
Table 19. New England Biolabs Eukaryotic Expression Systems Total Revenue (USD Million) (2017-2018)
Table 20. New England Biolabs SWOT Analysis
Table 21. New England Biolabs Eukaryotic Expression Systems Product and Solutions
Table 22. New England Biolabs Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Sigma Aldrich Corporate Information, Location and Competitors
Table 24. Sigma Aldrich Eukaryotic Expression Systems Major Business
Table 25. Sigma Aldrich Eukaryotic Expression Systems Total Revenue (USD Million) (2017-2018)
Table 26. Sigma Aldrich SWOT Analysis
Table 27. Sigma Aldrich Eukaryotic Expression Systems Product and Solutions
Table 28. Sigma Aldrich Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Promega Corporate Information, Location and Competitors
Table 30. Promega Eukaryotic Expression Systems Major Business
Table 31. Promega Eukaryotic Expression Systems Total Revenue (USD Million) (2017-2018)
Table 32. Promega SWOT Analysis
Table 33. Promega Eukaryotic Expression Systems Product and Solutions
Table 34. Promega Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Jena Bioscience Corporate Information, Location and Competitors
Table 36. Jena Bioscience Eukaryotic Expression Systems Major Business
Table 37. Jena Bioscience Eukaryotic Expression Systems Total Revenue (USD Million) (2017-2018)
Table 38. Jena Bioscience SWOT Analysis
Table 39. Jena Bioscience Eukaryotic Expression Systems Product and Solutions
Table 40. Jena Bioscience Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Bio Rad Corporate Information, Location and Competitors
Table 42. Bio Rad Eukaryotic Expression Systems Major Business
Table 43. Bio Rad Eukaryotic Expression Systems Total Revenue (USD Million) (2017-2018)
Table 44. Bio Rad SWOT Analysis
Table 45. Bio Rad Eukaryotic Expression Systems Product and Solutions
Table 46. Bio Rad Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Takara Bio Corporate Information, Location and Competitors
Table 48. Takara Bio Eukaryotic Expression Systems Major Business
Table 49. Takara Bio Eukaryotic Expression Systems Total Revenue (USD Million) (2017-2018)
Table 50. Takara Bio SWOT Analysis
Table 51. Takara Bio Eukaryotic Expression Systems Product and Solutions
Table 52. Takara Bio Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Merck Millipore Corporate Information, Location and Competitors
Table 54. Merck Millipore Eukaryotic Expression Systems Major Business
Table 55. Merck Millipore Eukaryotic Expression Systems Total Revenue (USD Million) (2017-2018)
Table 56. Merck Millipore SWOT Analysis
Table 57. Merck Millipore Eukaryotic Expression Systems Product and Solutions
Table 58. Merck Millipore Eukaryotic Expression Systems Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Eukaryotic Expression Systems Revenue (Million USD) by Players (2015-2020)
Table 60. Global Eukaryotic Expression Systems Revenue Share by Players (2015-2020)
Table 61. Global Eukaryotic Expression Systems Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Eukaryotic Expression Systems Revenue Market Share by Regions (2015-2020)
Table 63. North America Eukaryotic Expression Systems Revenue by Countries (2015-2020)
Table 64. North America Eukaryotic Expression Systems Revenue Market Share by Countries (2015-2020)
Table 65. Europe Eukaryotic Expression Systems Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Eukaryotic Expression Systems Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Eukaryotic Expression Systems Revenue by Countries (2015-2020)
Table 68. South America Eukaryotic Expression Systems Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Eukaryotic Expression Systems Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Eukaryotic Expression Systems Revenue Market Share by Countries (2015-2020)
Table 71. Global Eukaryotic Expression Systems Revenue (Million USD) by Type (2015-2020)
Table 72. Global Eukaryotic Expression Systems Revenue Share by Type (2015-2020)
Table 73. Global Eukaryotic Expression Systems Revenue Forecast by Type (2021-2025)
Table 74. Global Eukaryotic Expression Systems Revenue by Application (2015-2020)
Table 75. Global Eukaryotic Expression Systems Revenue Share by Application (2015-2020)
Table 76. Global Eukaryotic Expression Systems Revenue Forecast by Application (2021-2025)
Table 77. Global Eukaryotic Expression Systems Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Eukaryotic Expression Systems Picture
Figure 2. Global Eukaryotic Expression Systems Revenue Market Share by Type in 2019
Figure 3. MEL Picture
Figure 4. COS Picture
Figure 5. CHO Picture
Figure 6. Insect cells Picture
Figure 7. Eukaryotic Expression Systems Revenue Market Share by Application in 2019
Figure 8. Reagents Picture
Figure 9. Expression vectors Picture
Figure 10. Competent cells Picture
Figure 11. Global Eukaryotic Expression Systems Revenue (USD Million) and Growth Rate (2015-2025)
Figure 12. North America Eukaryotic Expression Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Europe Eukaryotic Expression Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Asia-Pacific Eukaryotic Expression Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. South America Eukaryotic Expression Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Middle East and Africa Eukaryotic Expression Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global Eukaryotic Expression Systems Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global Eukaryotic Expression Systems Revenue Share by Players in 2019
Figure 19. Global Top 5 Players Eukaryotic Expression Systems Revenue Market Share in 2019
Figure 20. Global Top 10 Players Eukaryotic Expression Systems Revenue Market Share in 2019
Figure 21. Key Players Market Share Trend
Figure 22. Global Eukaryotic Expression Systems Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 23. Global Eukaryotic Expression Systems Revenue Market Share by Regions (2015-2020)
Figure 24. Global Eukaryotic Expression Systems Revenue Market Share by Regions in 2018
Figure 25. North America Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 26. Europe Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 27. Asia-Pacific Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 28. South America Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 29. Middle East and Africa Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 30. North America Eukaryotic Expression Systems Revenue Market Share by Countries (2015-2020)
Figure 31. North America Eukaryotic Expression Systems Revenue Market Share by Countries in 2019
Figure 32. USA Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 33. Canada Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 34. Mexico Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 35. Europe Eukaryotic Expression Systems Revenue Market Share by Countries (2015-2020)
Figure 36. Europe Eukaryotic Expression Systems Revenue Market Share by Countries in 2019
Figure 37. Germany Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 38. UK Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 39. France Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 40. Russia Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 41. Italy Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Eukaryotic Expression Systems Revenue Market Share by Countries (2015-2020)
Figure 43. Asia-Pacific Eukaryotic Expression Systems Revenue Market Share by Countries in 2019
Figure 44. China Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 45. Japan Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 46. Korea Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 47. India Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 48. Southeast Asia Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 49. South America Eukaryotic Expression Systems Revenue Market Share by Countries (2015-2020)
Figure 50. South America Eukaryotic Expression Systems Revenue Market Share by Countries in 2019
Figure 51. Brazil Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 52. Argentina Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 53. Middle East and Africa Eukaryotic Expression Systems Revenue Market Share by Countries (2015-2020)
Figure 54. Middle East and Africa Eukaryotic Expression Systems Revenue Market Share by Countries in 2019
Figure 55. Saudi Arabia Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 56. UAE Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 57. Egypt Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 58. South Africa Eukaryotic Expression Systems Revenue and Growth Rate (2015-2020)
Figure 59. Global Eukaryotic Expression Systems Revenue Share by Type (2015-2020)
Figure 60. Global Eukaryotic Expression Systems Revenue Share by Type in 2019
Figure 61. Global Eukaryotic Expression Systems Market Share Forecast by Type (2021-2025)
Figure 62. Global MEL Revenue Growth Rate (2015-2020)
Figure 63. Global COS Revenue Growth Rate (2015-2020)
Figure 64. Global CHO Revenue Growth Rate (2015-2020)
Figure 65. Global Insect cells Revenue Growth Rate (2015-2020)
Figure 66. Global Eukaryotic Expression Systems Revenue Share by Application (2015-2020)
Figure 67. Global Eukaryotic Expression Systems Revenue Share by Application in 2019
Figure 68. Global Eukaryotic Expression Systems Market Share Forecast by Application (2021-2025)
Figure 69. Global Reagents Revenue Growth Rate (2015-2020)
Figure 70. Global Expression vectors Revenue Growth Rate (2015-2020)
Figure 71. Global Competent cells Revenue Growth Rate (2015-2020)
Figure 72. Global Eukaryotic Expression Systems Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 73. Global Eukaryotic Expression Systems Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 74. Global Eukaryotic Expression Systems Revenue Market Share Forecast by Regions (2021-2025)
Figure 75. North America Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
Figure 76. Europe Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
Figure 77. Asia-Pacific Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
Figure 78. South America Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
Figure 79. Middle East and Africa Eukaryotic Expression Systems Revenue Market Forecast (2021-2025)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
昆虫細胞発現システムの世界市場レポート2020 Market Analysis and Insights: Global Insect Cell Expression Systems Market The global Insect Cell Expression Systems market was valued at US$ xx million in 2019 and will reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2020-2026. Global Insect Cell Expression Systems Scope an…- 真核生物DNAポリメラーゼの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Eukaryotic DNA Polymerase market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Eukaryotic DNA Poly…
- レンチウイルス発現システムの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Lentiviral Expression Systems market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Lentiviral Expr…
- 発現ベクターの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Expression Vectors market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 305.4 million by 2025, from USD 258.4 million in 2019. The Expression Vectors …
- ORF発現クローンの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global ORF Expression Clones market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The ORF Expression Clones m…